[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU3478200A - Method of manufacture for transdermal matrices - Google Patents

Method of manufacture for transdermal matrices

Info

Publication number
AU3478200A
AU3478200A AU34782/00A AU3478200A AU3478200A AU 3478200 A AU3478200 A AU 3478200A AU 34782/00 A AU34782/00 A AU 34782/00A AU 3478200 A AU3478200 A AU 3478200A AU 3478200 A AU3478200 A AU 3478200A
Authority
AU
Australia
Prior art keywords
manufacture
transdermal matrices
transdermal
matrices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34782/00A
Inventor
Jay D. Audett
Georges D. Detroyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU3478200A publication Critical patent/AU3478200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
AU34782/00A 1999-02-02 2000-02-01 Method of manufacture for transdermal matrices Abandoned AU3478200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24166299A 1999-02-02 1999-02-02
US09241662 1999-02-02
PCT/US2000/002491 WO2000045797A1 (en) 1999-02-02 2000-02-01 Method of manufacture for transdermal matrices

Publications (1)

Publication Number Publication Date
AU3478200A true AU3478200A (en) 2000-08-25

Family

ID=22911658

Family Applications (2)

Application Number Title Priority Date Filing Date
AU34782/00A Abandoned AU3478200A (en) 1999-02-02 2000-02-01 Method of manufacture for transdermal matrices
AU29784/00A Abandoned AU2978400A (en) 1999-02-02 2000-02-01 Method of manufacture for transdermal matrices

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU29784/00A Abandoned AU2978400A (en) 1999-02-02 2000-02-01 Method of manufacture for transdermal matrices

Country Status (3)

Country Link
AR (1) AR022471A1 (en)
AU (2) AU3478200A (en)
WO (2) WO2000045798A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018649B2 (en) 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods
ES2309107T3 (en) * 2000-10-23 2008-12-16 Euro-Celtique S.A. DEVICE AND TRANSDERMIC METHODS FOR PHELODIPINE.
DE10056011A1 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Well tolerated plaster for controlled delivery of essential oils to skin or air, has active agent containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and optionally filler
DE10056010A1 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Well tolerated plaster for controlled delivery of cosmetic skin care agents, having active agent-containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and optionally filler
DE10056009A1 (en) * 2000-11-11 2002-05-16 Beiersdorf Ag Well tolerated plaster for controlled delivery of hyperemic agents, having active agent-containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and filler
US20030069482A1 (en) * 2001-10-09 2003-04-10 Workman Jerome James Sampling article for determining quantitative and qualitative drug transfer to skin
DE10157745A1 (en) * 2001-11-24 2003-06-26 Hf Arzneimittelforsch Gmbh Transdermal therapeutic system for the administration of 17alpha-estradiol
US20040062813A1 (en) * 2002-06-28 2004-04-01 Cormier Michel J. N. Transdermal drug delivery devices having coated microprotrusions
AU2003246124A1 (en) * 2002-07-01 2004-01-19 Matsushita Electric Industrial Co., Ltd. Optical disc, optical disc recording device, optical disc recording method
DE10236319A1 (en) * 2002-08-08 2004-02-19 Beiersdorf Ag Active agent containing matrix plaster for the controlled delivery of an active agent to the skin comprises a pharmaceutical active agent containing a water insoluble adhesive matrix comprising a styrene block copolymer
JP4528296B2 (en) 2003-02-21 2010-08-18 シェーリング アーゲー UV stable transdermal ointment
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
DE102004038533A1 (en) * 2004-08-09 2006-02-23 Beiersdorf Ag Hydrous polymer matrix of hydrophobic polymers
DE602005021541D1 (en) 2004-12-07 2010-07-08 3M Innovative Properties Co METHOD FOR MOLDING A MICRONADEL
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
AU2006261899B2 (en) 2005-06-27 2012-05-10 Kindeva Drug Delivery L.P. Microneedle cartridge assembly and method of applying
DE102005033943A1 (en) * 2005-07-20 2007-02-22 Hexal Ag Non-spitting, oral, fast-disintegrating film for a neuroleptic
DE102008059054A1 (en) 2008-11-26 2010-05-27 Otto Bock Pur Life Science Gmbh Polyurethane patch for the transdermal application of active substances and process for its preparation
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
DE102011090178A1 (en) 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with low tendency to spontaneous crystallization
WO2014105480A1 (en) * 2012-12-28 2014-07-03 Teikoku Pharma Usa, Inc. Extended buprenorphine transdermal delivery compositions and methods for using the same
WO2014134510A1 (en) 2013-02-28 2014-09-04 Dermira, Inc. Glycopyrrolate salts
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
CN108721204A (en) * 2018-06-04 2018-11-02 南京紫源康医药科技有限公司 A kind of solubility alkannin microneedle patch and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
DE19728517C2 (en) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS for the administration of sex steroid hormones and process for its preparation

Also Published As

Publication number Publication date
AR022471A1 (en) 2002-09-04
WO2000045798A1 (en) 2000-08-10
AU2978400A (en) 2000-08-25
WO2000045797A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
AU3478200A (en) Method of manufacture for transdermal matrices
AU2557500A (en) Methods of making compounds
AUPP337298A0 (en) Process for microgel preparation
AU6487600A (en) Process for production of an etheralcohol
AU4277700A (en) Method for removal of sic
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU1055001A (en) Method for immobilizing material
AU1036601A (en) Method of screening for inhibitors of asp1
AU4631800A (en) Process for production of an acrylate composition
AU1412401A (en) Method for production of porous material
AU1412501A (en) Method for production of porous material
AU4750000A (en) Method for production of microcapsules
AU2002350903A1 (en) Method for forming matrices of hardened material
AU1037901A (en) Process for the preparation of paroxetine
AU3818900A (en) Process for the preparation of substituted piperidines
AU3843900A (en) Microbiological production method for alpha-l-aspartyl-l-phenylalanine
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU3161701A (en) Method for producing nitroguanidine
AU6031300A (en) Method for supervision of parallel processes
AU1283001A (en) Method for producing alkylhalogenosilanes
AU4598400A (en) Method of treatment
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
AU2382601A (en) Novel method of treatment
AU6691600A (en) Method for producing 4-cyano-2-aminomethylthiazol

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase